Evaluation of Non-Surgical and Arthroscopic Treatment for Hip Microinstability

NCT ID: NCT04934462

Last Updated: 2025-03-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

26 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-11-26

Study Completion Date

2026-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Microinstability of the hip joint is an important cause of hip pain and reduced hip function in young and active individuals. Hip microinstability is due to extraphysiologic hip motion and could be secondary to acetabular dysplasia, connective tissue disorder, macrotrauma, microtrauma, iatrogenic- and idiopathic causes. Treatment for hip microinstability is initiated with non-surgical treatment consisting of physiotherapy aimed mainly at stability. If non-surgical treatment fails, surgery with arthroscopic plication of the hip joint capsule is the preferred method. This study evaluates non-surgical and arthroscopic treatment for hip microinstability regarding hip function and adverse events.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a prospective cohort study evaluating 26 participants above 18 years of age undergoing non-surgical and surgical treatment for microinstability of the hip joint. Participants with findings on physical examination and imaging suggestive of hip microinstability will undergo six months of physiotherapy aimed at stabilizing the hip joint. If non-surgical treatment fails, a diagnostic hip arthroscopy will be performed, and if hip microinstability is confirmed, the participants will undergo a plication of the hip joint capsule. Participants will be evaluated with Patient-Reported Outcome Scores (PROMs) and strength- and function tests at time of enrollment and at 6-, 12- and 24 months following treatment. The primary outcome is hip function determined by PROMs and strength- and function tests. Secondary outcomes include Health-Related Quality of Life (HRQL), sport activity level and adverse events.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Musculoskeletal Abnormalities Hip Injuries

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

non-surgical treatment

All participants will undergo 6 months of non-surgical treatment.

Group Type OTHER

physiotherapy

Intervention Type PROCEDURE

Six months physiotherapy aimed at hip stability.

arthroscopic treatment

Those participants with failed non-surgical treatment at 6 months will undergo arthroscopic treatment.

Group Type OTHER

physiotherapy

Intervention Type PROCEDURE

Six months physiotherapy aimed at hip stability.

arthroscopy

Intervention Type PROCEDURE

Arthroscopic plication of hip joint capsule.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

physiotherapy

Six months physiotherapy aimed at hip stability.

Intervention Type PROCEDURE

arthroscopy

Arthroscopic plication of hip joint capsule.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Hip microinstability
* Minimum 18 years old

Exclusion Criteria

* Hip osteoarthritis
* Severe hip dysplasia
* Perthes disease or avascular necrosis of the femoral head
* Previous surgery to the hip joint
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Swedish Society of Medicine

OTHER

Sponsor Role collaborator

Stanford University

OTHER

Sponsor Role collaborator

Göteborg University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mikael Sansone, MD, PhD

Role: STUDY_DIRECTOR

Göteborg University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

GHP Ortho Center Göteborg

Gothenburg, , Sweden

Site Status NOT_YET_RECRUITING

University of Gothenburg

Gothenburg, , Sweden

Site Status RECRUITING

Capio Artro Clinic

Stockholm, , Sweden

Site Status NOT_YET_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Sweden

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Axel Öhlin, MD, PhD

Role: CONTACT

00460313430752

Mikael Sansone, MD, PhD

Role: CONTACT

00460313430336

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mattias Ahldén, MD, PhD

Role: primary

Axel Öhlin, MD, PhD

Role: primary

0313430752 ext. 0046

Anders Stålman, MD, PhD

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Ohlin A, Senorski EH, Sansone M, Leff G, Desai N, Lindman I, Ayeni OR, Safran MR. Protocol for a multicenter prospective cohort study evaluating arthroscopic and non-surgical treatment for microinstability of the hip joint. BMC Musculoskelet Disord. 2022 Mar 31;23(1):309. doi: 10.1186/s12891-022-05269-x.

Reference Type DERIVED
PMID: 35361185 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Hip Microinstability Study

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.